DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
DongKoo Bio & Pharma Co Ltd
Research & Development
DongKoo Bio & Pharma Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
|
Research & Development
-₩9.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Research & Development
-₩197B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-19%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Research & Development
-₩162.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Research & Development
-₩189.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Research & Development
-₩8.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Research & Development
-₩5.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
DongKoo Bio & Pharma Co Ltd
Glance View
DongKoo Bio & Pharm Co. Ltd. operates as a holding company engaged in the manufacture and sale of pharmaceutical products and health supplements. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-02-13. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The major products include antihistamines, topical steroids, therapeutic agents for prostatitis, treatments for benign prostatic hyperplasia, atherosclerotic agents, and antibiotics, among others. The firm is involved in contract manufacturing organization business. The company manufactures and sells therapeutic for osteoporosis, antiviral agents, erectile dysfunction treatments, hepatic disease agents; painkillers; gum treatments. In addition, the Company is engaged in the manufacturing and sale of medical devices and cosmetics. The firm distributes its products within the domestic market and to overseas markets, including America and Europe.
See Also
What is DongKoo Bio & Pharma Co Ltd's Research & Development?
Research & Development
-9.8B
KRW
Based on the financial report for Sep 30, 2025, DongKoo Bio & Pharma Co Ltd's Research & Development amounts to -9.8B KRW.
What is DongKoo Bio & Pharma Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
1%
Over the last year, the Research & Development growth was -2%. The average annual Research & Development growth rates for DongKoo Bio & Pharma Co Ltd have been -6% over the past three years , 1% over the past five years .
